Adaptive Biotechnologies vs CDR3
Adaptive Biotechnologies vs CDR3, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and CDR3 on 14/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 14/100
- agent readiness: 39/100 against 21/100
CDR3
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptive Biotechnologies | CDR3 |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Healthcare, Immunology, Genomics, Computational Biology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Software |
| Founded | 2009 | 2018 |
| Headquarters | Seattle, United States | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Adaptive Biotechnologies | CDR3 |
|---|---|---|
| Total funding | $300M | Not published |
| Latest round | Series D | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | CDR3 |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 14/100 |
| Team | Not published | 30/100 |
| Search visibility | Not published | 4/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 61/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | CDR3 |
|---|---|---|
| Hosting | Self Managed | Google Cloud |
| CMS | WordPress | Wix |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
Adaptive Biotechnologies vs CDR3: common questions
Which is better, Adaptive Biotechnologies or CDR3?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 14/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and CDR3 compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 14/100), agent readiness (39/100 against 21/100).
Read the full Adaptive Biotechnologies review and pricing or the CDR3 review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.